
Nanoceria: Synthesis and Biomedical Applications
Cerium oxide or ceria is an inorganic compound of Cerium, a rare earth element of lanthanide series. Due to the unique ability of cerium to switch oxidation states between +3 and +4 it has various applications as ultraviolet light absorbers, catalytic converters for automobile
exhaust systems, solar cells, optics, oxygen sensors and other commercial and biomedical applications. Cerium oxide nanoparticles popularly known as nanoceria are efficient free radical scavengers and are considered as a potent therapeutic option for the treatment of ROS mediated disorders
like neurodegenerative disorders, retinal disorders, cancer and can also act as a potent drug delivery agent. Engineered nanoparticles have the potential to revolutionize diagnosis and treatment of many diseases which require the synthesis of nanoceria with biocompatibility so as to enhance
its therapeutic potential without inducing any cytotoxicity. Here we review the various methods for synthesis of nanoceria for biomedical applications and we discuss the challenges to realize the potential of nanoceria in therapeutics.
Keywords: Antioxidants; biocompatibility; cytotoxicity; drug delivery; nanoceria; nanoparticle; therapeutics
Document Type: Research Article
Publication date: October 1, 2013
- Current Nanoscience publishes authoritative reviews and original research reports, written by experts in the field on all the most recent advances in nanoscience and nanotechnology. All aspects of the field are represented including nano- structures, synthesis, properties, assembly and devices. Applications of nanoscience in biotechnology, medicine, pharmaceuticals, physics, material science and electronics are also covered. The journal is essential to all involved in nanoscience and its applied areas.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Call for Papers
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content